Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
Funds basic research to understand how seasonal influenza spreads from person to person. Awardees will form an Influenza Transmission Research Consortium made up of multiple research centers. Each center should have a collaborative, multidisciplinary team that will:
- Study the mechanisms, dynamics, and drivers of human-to-human influenza transmission
- Develop new tools, dat…
The purpose of this notice of funding opportunity (NOFO) is to support basic research to understand the fundamental mechanisms underlying human-to-human transmission of seasonal influenza virus. The NOFO will establish an Influenza Transmission Research Consortium comprised of a network of indiv…
Source
Awards & funding
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving …
Tags
Supporting links
Documents
Similar opportunities
-
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
-
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed)
-
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine
-
Tuberculosis Research Units (P01 Clinical Trial Optional)
-
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)